Sarepta therapeutics news

See also: Sarepta therapeutics cambridgeSarepta therapeuticsSarepta therapeutics.comSarepta therapeutics ceoSarepta therapeutics 10kSarepta therapeutics ark

Keywords Suggestions

Sarepta therapeutics news

Sarepta therapeutics news today

Sarepta therapeutics inc news

( Please select at least 2 keywords )

Related websites

News & Press Releases Sarepta Therapeutics

  • Sarepta Therapeutics Opens Genetic Therapies Center of Excellence in Columbus, Ohio
  • Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
  • Sarepta Therapeutics Announces Inducement

Sarepta.com   DA: 15 PA: 9 MOZ Rank: 25

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • It’s the Latest ‘Bad’ News
  • Sarepta Therapeutics stock is falling after the biotech company said it would sell more stock and provided an update on product revenue

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 36

Buy or Sell Sarepta Therapeutics Inc. (SRPT) Stock Now

  • (NASDAQ:SRPT) went down by -3.53% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected -11.03% of loss in the last five trading sessions

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 67

Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports

  • 2 days ago · Sarepta Therapeutics Inc
  • (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results
  • The company expects net product revenues of $166.9 million relative to net revenue of $121.4 million a year ago
  • Sarepta has $1.6 billion in cash and equivalents

Biopharmajournal.com   DA: 20 PA: 50 MOZ Rank: 74

What's Next For Sarepta Stock After A 12% Fall

The stock price of Sarepta Therapeutics (NASDAQ:SRPT), a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for …

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 69

Do Analysts Agree Wednesday on Sarepta Therapeutics Inc

  • Sarepta Therapeutics Inc (SRPT) stock has fallen -1.85% while the S&P 500 has risen 0.15% as of 1:27 PM on Wednesday, Oct 20
  • SRPT has fallen -$1.49 from the previous closing price of $80.44 on volume of 515,325 shares

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 81

Sarepta Therapeutics Reports Positive Clinical Results

  • CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced positive results from Part

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 74

Why Sarepta Therapeutics Fell 14.7% This Week The Motley

  • Sarepta Therapeutics ( NASDAQ:SRPT), a biotech company that specializes in genetic therapies for rare diseases, dropped 14.7% this week, according to data from S&P Global Market Intelligence

Fool.com   DA: 12 PA: 50 MOZ Rank: 70

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ:SRPT) stock fell by over 12% today
  • Investors were displeased with a company update about its

Fool.com   DA: 12 PA: 50 MOZ Rank: 71

Sarepta Therapeutics Inc. (SRPT): Skating on Thin Ice

  • (NASDAQ:SRPT) went up by 4.70% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected 7.38% of gains in the last five trading sessions
  • Press Release reported on 09/14/21 that Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual …

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 74

SRPT News Today (Sarepta Therapeutics) MarketBeat

  • (NASDAQ:SRPT) Given Average Recommendation of "Buy" by Analysts
  • americanbankingnews.com - September 19 at 8:36 AM
  • Even after rising 6.4% this past week, Sarepta Therapeutics (NASDAQ:SRPT) shareholders are still down 44% over the past three years
  • finance.yahoo.com - September 17 at 1:14 PM.

Marketbeat.com   DA: 18 PA: 25 MOZ Rank: 54

Sarepta Therapeutics Announces Pricing of $500 Million

  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for …

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 79

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Get the latest news and real-time alerts from Sarepta Therapeutics, Inc

Seekingalpha.com   DA: 16 PA: 17 MOZ Rank: 46

Sarepta Therapeutics Biopharmaceutical Company for Rare

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/2021 Sarepta Therapeutics Announces Proposed $500,000,000 Public …

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 44

Sarepta Therapeutics Announces Pricing of $500 Million

  • Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock 10/13/21 9:15 PM EDT CAMBRIDGE, Mass., Oct
  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of 6,172,840

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 94

Sarepta Therapeutics Enters into Long-term Strategic

  • Source: Sarepta Therapeutics, Inc
  • Media and Investors: Sarepta Therapeutics, Inc
  • Ian Estepan, 617-274-4052 [email protected] or W2O Group Rachel Hutman, 301-801-5540 [email protected]
  • Corporate Contact: Philip Wills, Chief Commercial Officer PH (410) 975-4050
  • Media Contact: PressComm PR Jamie Lacey-Moreira PH

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 95

SRPT -- Is Its Stock Price A Worthy Investment

  • It’s the Latest ‘Bad’ News
  • Sarepta Therapeutics stock is falling after the biotech company said it would sell more stock and provided an update on product revenue
  • Sarepta said that it would post third-quarter sales of $166.9 million
  • Sarepta stock had 6.6% in premarket trading after gaining 4.1% on Tuesday.

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 42

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, Quote

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 46

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 59

Sarepta Therapeutics Stock Is Estimated To Be Possible

  • Sarepta Therapeutics has been profitable 0 over the past 10 years
  • Over the past twelve months, the company had a revenue of $573.4 million and loss of $8.94 a share.

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 87

Investor Relations Sarepta Therapeutics, Inc.

  • FRONT >> News > View All Archived Press Releases Events & Presentations
  • Date Title; 10/11/21 at 8:30 AM EDT SRP-9001 Micro-dystrophin R&D Day
  • 09/27/21 at 1:20 PM EDT Sarepta Therapeutics at the Cantor Fitzgerald Virtual Global Healthcare Conference
  • 09/20 - 09/24/21 2021 World Muscle Society Virtual Congress
  • FRONT >> Events > View All

Investorrelations.sarepta.com   DA: 29 PA: 29 MOZ Rank: 79

Sarepta Therapeutics (SRPT) Stock Analysis: Price

  • Sarepta Therapeutics (SRPT) Company Description Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases
  • It targets a broad range of diseases while focusing on the rapid development of its drug candidates.

Investorsobserver.com   DA: 25 PA: 18 MOZ Rank: 65

Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) News

  • Find the latest news headlines from Sarepta Therapeutics, Inc
  • Common Stock (DE) (SRPT) at Nasdaq.com.

Nasdaq.com   DA: 14 PA: 43 MOZ Rank: 80

Sarepta Therapeutics Inc (SRPT) News

  • Sarepta Therapeutics Announces Second Quarter 2021 Financial Results and Recent Corporate Developments
  • Provided by GlobeNewswire Aug 4, 2021 1:05 PM PDT

Morningstar.com   DA: 19 PA: 22 MOZ Rank: 65

Sarepta Therapeutics (SRPT) Stock Price, News & Info The

Real time Sarepta Therapeutics (SRPT) stock price quote, stock graph, news & analysis.

Fool.com   DA: 12 PA: 19 MOZ Rank: 56

Sarepta Therapeutics News

  • Sarepta Therapeutics (SRPT) stock price, charts, trades & the US's most popular discussion forums
  • Free forex prices, toplists, indices and lots more

Advfn.com   DA: 13 PA: 30 MOZ Rank: 69

SRPT Stock Forecast, Price & News (Sarepta Therapeutics)

  • Sign-up to receive the latest news and ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter
  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 65

What Do Analysts Think Of Sarepta Therapeutics Inc. (SRPT

  • (SRPT) saw an uptrend of 0.95% in the recent trading with $69.11 being its most recent
  • The current price level -61.99% lower than the highest price of $181.83 marked by the stock while trading over the past 52-weeks, whereas it is 5.74% higher than the lowest price of $65.36 the company dropped to over past 52-weeks.

Baxterreport.com   DA: 16 PA: 50 MOZ Rank: 94

Should You Buy Sarepta Therapeutics Inc (SRPT) Stock After

  • Sarepta Therapeutics Inc (SRPT) stock is trading at $79.32 as of 11:49 AM on Wednesday, Aug 25, a gain of $1.97, or 2.55% from the previous closing price of $77.35
  • The stock has traded between $76.38 and $79.79 so far today

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 21

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • View the latest Sarepta Therapeutics Inc
  • (SRPT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Wsj.com   DA: 11 PA: 24 MOZ Rank: 65

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 59

SRPT: Sarepta Therapeutics Inc

Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 56

Sarepta Therapeutics Announces Recipients of Route 79, The

  • Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program 09/07/21 8:30 AM EDT CAMBRIDGE, Mass., Sept
  • 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced fifteen recipients of Route 79, The Duchenne Scholarship Program.

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 17

Sarepta Therapeutics Announces Preliminary Financial

  • 12, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced preliminary financial results for its third quarter ended September 30, 2021
  • Sarepta expects its net product revenues for the quarter to be approximately $166.9 million, compared to net product …

Nz.news.yahoo.com   DA: 17 PA: 50 MOZ Rank: 16

Sarepta Therapeutics (SRPT): I was waiting for 120. And

  • Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quar-ter Ended September 30, 2021 GlobeNewswire Inc
  • - 10/12/2021 4:04:00 PM: Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock GlobeNewswire Inc

Investorshub.advfn.com   DA: 22 PA: 21 MOZ Rank: 78

Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional

  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 14

Sarepta Therapeutics Announces Initiation of EMBARK, a

  • - Sarepta to host SRP-9001 Micro-dystrophin R&D Day at 8:30 a.m

Eresearch.fidelity.com   DA: 22 PA: 45 MOZ Rank: 13

Sarepta Therapeutics Announces Partnership with Roche in

  • 23, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that Sarepta and Roche have entered into a licensing agreement providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), Sarepta’s

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 12

Sarepta Therapeutics (NASDAQ:SRPT) Coverage Initiated at

  • Shares of SRPT opened at $97.28 on Thursday
  • Sarepta Therapeutics has a 52-week low of $65.30 and a 52-week high of $181.83
  • The company has a debt-to-equity ratio of 2.25, a quick ratio of 4.70 and a current ratio of 5.33
  • The business's 50 day moving average price is $81.30 and its two-hundred day moving average price is $76.94.

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 11

Sarepta Therapeutics News

  • Sarepta Therapeutics news and SRPT price
  • Free real-time prices, trades, and chat.

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 10

Meet Our Leadership Sarepta Therapeutics

  • Meet Our Leadership | Sarepta Therapeutics
  • President and Chief Executive Officer
  • “We know why we get up every day and work as hard as we do
  • People living with rare diseases and their families are relying on us for their futures." Read more

Sarepta.com   DA: 15 PA: 20 MOZ Rank: 76

Sarepta Therapeutics (SRPT): Down 50%

  • Sarepta Therapeutics (SRPT): Down 50%
  • Published on January 13, 2021 at 11:56 am by Fahad Ali Khan in Market Movers, News, Stock Analysis
  • (NASDAQ: SRPT) is a commercial

Insidermonkey.com   DA: 21 PA: 47 MOZ Rank: 8

Sarepta Therapeutics: SRPT Stock Price Quote & News

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases
  • The company was founded on July 22, 1980 and is headquartered in Cambridge, MA

Robinhood.com   DA: 13 PA: 12 MOZ Rank: 68

Sarepta Therapeutics: Faultlines May Run Deeper Than

  • Sarepta Therapeutics stock went down over 50% after poor January data
  • Unless it can prove functional benefit from its DMD drugs, SRPT stock may not be able to get back up on its feet.

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 6

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Tunefab.com 107 days leftGoDaddy.com, LLCDomain Name Services
Akaiaoi.com 81 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Simplymadebyrebecca.com 155 days leftNameCheap, Inc.Google LLC
Wesleymc.com2 years, 27 days leftMarkMonitor Inc.HCA Hospital Corporation of America
Hm-lock.com 203 days lefteName Technology Co., Ltd.Transferred to the RIPE region on 2018-08-27T14:42:34Z.
Goons-io.com 25 days leftNameSilo, LLCNew Dream Network, LLC
Shoubido.com 123 days leftGMO Internet, Inc. d/b/a Onamae.comASAHI Net,Inc.
Vickstricks.com 72 days leftGoDaddy.com, LLCCloudflare, Inc.
Stovax.com1 year, 229 days leftTucows Domains Inc.Media Temple, Inc.
Sccoach.com2 years, 158 days leftGoDaddy.com, LLCAmazon Technologies Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]